China Pet Cancer Therapeutics Market Report & Forecast 2021-2027

List of Figures, Tables and Charts Available in China Pet Cancer Therapeutics Market Report & Forecast 2021-2027

List of Tables
Table 1. Key Players of Pet Cancer Therapeutics in China Market
Table 2. Top Pet Cancer Therapeutics Players in China Market, Ranking by Revenue (2019)
Table 3. China Pet Cancer Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Pet Cancer Therapeutics Revenue Share by Companies, 2016-2021
Table 5. China Pet Cancer Therapeutics Sales by Companies, (K Units), 2016-2021
Table 6. China Pet Cancer Therapeutics Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pet Cancer Therapeutics Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Pet Cancer Therapeutics Product Type
Table 9. List of Tier 1 Pet Cancer Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Pet Cancer Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Chemotherapy
Table 12. Major Manufacturers of Targeted Therapy
Table 13. By Type – China Pet Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Pet Cancer Therapeutics Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Pet Cancer Therapeutics Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Pet Cancer Therapeutics Sales (K Units), 2016-2021
Table 17. By Type - China Pet Cancer Therapeutics Sales (K Units), 2022-2027
Table 18. By Application – China Pet Cancer Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Pet Cancer Therapeutics Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Pet Cancer Therapeutics Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Pet Cancer Therapeutics Sales (K Units), 2016-2021
Table 22. By Application - China Pet Cancer Therapeutics Sales (K Units), 2022-2027
Table 23. Aratana Therapeutics, Inc Corporation Information
Table 24. Aratana Therapeutics, Inc Description and Major Businesses
Table 25. Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Aratana Therapeutics, Inc Pet Cancer Therapeutics Product
Table 27. Aratana Therapeutics, Inc Recent Developments
Table 28. AB Science Corporation Information
Table 29. AB Science Description and Major Businesses
Table 30. AB Science Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. AB Science Pet Cancer Therapeutics Product
Table 32. AB Science Recent Developments
Table 33. Boehringer Ingelheim International GmbH Corporation Information
Table 34. Boehringer Ingelheim International GmbH Description and Major Businesses
Table 35. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product
Table 37. Boehringer Ingelheim International GmbH Recent Developments
Table 38. Zenoaq Corporation Information
Table 39. Zenoaq Description and Major Businesses
Table 40. Zenoaq Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Zenoaq Pet Cancer Therapeutics Product
Table 42. Zenoaq Recent Developments
Table 43. Morphogenesis, Inc Corporation Information
Table 44. Morphogenesis, Inc Description and Major Businesses
Table 45. Morphogenesis, Inc Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Morphogenesis, Inc Pet Cancer Therapeutics Product
Table 47. Morphogenesis, Inc Recent Developments
Table 48. VetDC, Inc Corporation Information
Table 49. VetDC, Inc Description and Major Businesses
Table 50. VetDC, Inc Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. VetDC, Inc Pet Cancer Therapeutics Product
Table 52. VetDC, Inc Recent Developments
Table 53. Karyopharm Therapeutics, Inc Corporation Information
Table 54. Karyopharm Therapeutics, Inc Description and Major Businesses
Table 55. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product
Table 57. Karyopharm Therapeutics, Inc Recent Developments
Table 58. Rhizen Pharmaceutical SA Corporation Information
Table 59. Rhizen Pharmaceutical SA Description and Major Businesses
Table 60. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product
Table 62. Rhizen Pharmaceutical SA Recent Developments
Table 63. Regeneus Ltd. Corporation Information
Table 64. Regeneus Ltd. Description and Major Businesses
Table 65. Regeneus Ltd. Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Regeneus Ltd. Pet Cancer Therapeutics Product
Table 67. Regeneus Ltd. Recent Developments
Table 68. Oasmia Pharmaceuticals AB Corporation Information
Table 69. Oasmia Pharmaceuticals AB Description and Major Businesses
Table 70. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product
Table 72. Oasmia Pharmaceuticals AB Recent Developments
Table 73. Zoetis Corporation Information
Table 74. Zoetis Description and Major Businesses
Table 75. Zoetis Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Zoetis Pet Cancer Therapeutics Product
Table 77. Zoetis Recent Developments
Table 78. Pet Cancer Therapeutics Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)
Table 79. China Pet Cancer Therapeutics Capacity Market Share of Key Manufacturers, 2019-2021
Table 80. Pet Cancer Therapeutics Market Opportunities & Trends in China Market
Table 81. Pet Cancer Therapeutics Market Drivers in China Market
Table 82. Pet Cancer Therapeutics Market Restraints in China Market
Table 83. Pet Cancer Therapeutics Raw Materials
Table 84. Pet Cancer Therapeutics Raw Materials Suppliers in China Market
Table 85. Typical Pet Cancer Therapeutics Downstream
Table 86. Pet Cancer Therapeutics Downstream Clients in China Market
Table 87. Pet Cancer Therapeutics Distributors and Sales Agents in China Market
List of Figures
Figure 1. Pet Cancer Therapeutics Product Picture
Figure 2. Pet Cancer Therapeutics Segment by Type
Figure 3. Pet Cancer Therapeutics Segment by Application
Figure 4. China Pet Cancer Therapeutics Market Overview: 2020
Figure 5. China Pet Cancer Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Pet Cancer Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. Pet Cancer Therapeutics Sales in China Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pet Cancer Therapeutics Revenue in 2020
Figure 9. Chemotherapy Product Picture
Figure 10. Targeted Therapy Product Picture
Figure 11. Combination Therapy Product Picture
Figure 12. Immunotherapy Product Picture
Figure 13. By Type - China Pet Cancer Therapeutics Sales Market Share, 2016-2027
Figure 14. By Type - China Pet Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 15. By Type - China Pet Cancer Therapeutics Price (USD/Unit), 2016-2027
Figure 16. Lymphoma
Figure 17. Mast Cell Cancer
Figure 18. Melanoma
Figure 19. Mammary
Figure 20. Squamous Cell Cancer
Figure 21. By Application - China Pet Cancer Therapeutics Sales Market Share, 2016-2027
Figure 22. By Application - China Pet Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 23. By Application - China Pet Cancer Therapeutics Price (USD/Unit), 2016-2027
Figure 24. Aratana Therapeutics, Inc Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. AB Science Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Zenoaq Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Morphogenesis, Inc Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. VetDC, Inc Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Regeneus Ltd. Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Zoetis Pet Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. China Pet Cancer Therapeutics Production Capacity (K Units), 2016-2027
Figure 36. Pet Cancer Therapeutics Industry Value Chain
Figure 37. Marketing Channels

Keyplayers in China Pet Cancer Therapeutics Market Report & Forecast 2021-2027

Aratana Therapeutics, Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics, Inc
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis